CS for CS for SB 1868                           Second Engrossed
       
       
       
       
       
       
       
       
       20091868e2
       
    1                        A bill to be entitled                      
    2         An act relating to the practice of pharmacy; amending
    3         ss. 465.003 and 465.019, F.S.; authorizing the use of
    4         an institutional formulary system in a Class I
    5         institutional pharmacy at which, with certain
    6         exceptions, all medicinal drugs are administered from
    7         individual prescription containers to the patient and
    8         medicinal drugs are not dispensed on the premises;
    9         specifying requirements for the policies and
   10         procedures of such an institutional formulary system;
   11         amending s. 627.4239, F.S.; revising the definition of
   12         the term “standard reference compendium” for purposes
   13         of regulating the insurance coverage of drugs used in
   14         the treatment of cancer; amending s. 456.42, F.S.;
   15         revising provisions specifying the information
   16         required to be included in written prescriptions for
   17         medicinal drugs; creating s. 465.1901, F.S.; providing
   18         that provisions of ch. 468, F.S., relating to
   19         orthotics and pedorthics do not apply to pharmacists;
   20         requiring the Board of Pharmacy to develop rules
   21         regarding the practice of orthotics and pedorthics by
   22         a pharmacist; repealing s. 468.812(3), F.S., relating
   23         to the practice of orthotics and pedorthics; amending
   24         s. 893.04, F.S.; authorizing a pharmacist to dispense
   25         a controlled substance and require photographic
   26         identification without documenting certain
   27         information; authorizing a pharmacist to dispense a
   28         controlled substance without verification of certain
   29         information by the prescriber under certain
   30         circumstances; providing an effective date.
   31  
   32  Be It Enacted by the Legislature of the State of Florida:
   33  
   34         Section 1. Paragraph (b) of subsection (1) of section
   35  627.4239, Florida Statutes, is amended to read:
   36         627.4239 Coverage for use of drugs in treatment of cancer.—
   37         (1) DEFINITIONS.—As used in this section, the term:
   38         (b) “Standard reference compendium” means an authoritative
   39  compendium identified by the Secretary of the United States
   40  Department of Health and Human Services and recognized by the
   41  federal Centers for Medicare and Medicaid Services:
   42         1.The United States Pharmacopeia Drug Information;
   43         2.The American Medical Association Drug Evaluations; or
   44         3.The American Hospital Formulary Service Drug
   45  Information.
   46         Section 2. Section 456.42, Florida Statutes, is amended to
   47  read:
   48         456.42 Written prescriptions for medicinal drugs.—A written
   49  prescription for a medicinal drug issued by a health care
   50  practitioner licensed by law to prescribe such drug must be
   51  legibly printed or typed so as to be capable of being understood
   52  by the pharmacist filling the prescription; must contain the
   53  name of the prescribing practitioner, the name and strength of
   54  the drug prescribed, the quantity of the drug prescribed in both
   55  textual and numerical formats, and the directions for use of the
   56  drug; must be dated with the month written out in textual
   57  letters; and must be signed by the prescribing practitioner on
   58  the day when issued. A written prescription for a controlled
   59  substance listed in chapter 893 must have the quantity of the
   60  drug prescribed in both textual and numerical formats and must
   61  be dated with the abbreviated month written out on the face of
   62  the prescription. However, a prescription that is electronically
   63  generated and transmitted must contain the name of the
   64  prescribing practitioner, the name and strength of the drug
   65  prescribed, the quantity of the drug prescribed in numerical
   66  format, and the directions for use of the drug and must be dated
   67  and signed by the prescribing practitioner only on the day
   68  issued, which signature may be in an electronic format as
   69  defined in s. 668.003(4).
   70         Section 3. Section 465.1901, Florida Statutes, is created
   71  to read:
   72         465.1901 Practice of orthotics and pedorthics.—The
   73  provisions of chapter 468 relating to orthotics or pedorthics do
   74  not apply to any licensed pharmacist or to any person acting
   75  under the supervision of a licensed pharmacist. The practice of
   76  orthotics or pedorthics by a pharmacist or any of the
   77  pharmacist’s employees acting under the supervision of a
   78  pharmacist shall be construed to be within the meaning of the
   79  term “practice of the profession of pharmacy” as set forth in s.
   80  465.003(13), and shall be subject to regulation in the same
   81  manner as any other pharmacy practice. The Board of Pharmacy
   82  shall develop rules regarding the practice of orthotics and
   83  pedorthics by a pharmacist. Any pharmacist or person under the
   84  supervision of a pharmacist engaged in the practice of orthotics
   85  or pedorthics is not precluded from continuing that practice
   86  pending adoption of these rules.
   87         Section 4. Subsection (3) of section 468.812, Florida
   88  Statutes, is repealed.
   89         Section 5. Paragraph (d) of subsection (2) of section
   90  893.04, Florida Statutes, is amended to read:
   91         893.04 Pharmacist and practitioner.—
   92         (2)
   93         (d) Each written prescription prescribed by a practitioner
   94  in this state for a controlled substance listed in Schedule II,
   95  Schedule III, or Schedule IV must include both a written and a
   96  numerical notation of the quantity of the controlled substance
   97  prescribed on the face of the prescription and a notation of the
   98  date, with the abbreviated month written out on the face of the
   99  prescription. A pharmacist may, upon verification by the
  100  prescriber, document any information required by this paragraph.
  101  If the prescriber is not available to verify a prescription, the
  102  pharmacist may dispense the controlled substance but may insist
  103  that the person to whom the controlled substance is dispensed
  104  provide valid photographic identification. If a prescription
  105  includes a numerical notation of the quantity of the controlled
  106  substance or date, but does not include the quantity or date
  107  written out in textual format, the pharmacist may dispense the
  108  controlled substance without verification by the prescriber of
  109  the quantity or date if the pharmacy previously dispensed
  110  another prescription for the person to whom the prescription was
  111  written.
  112         Section 6. This act shall take effect July 1, 2009.